Search

Lauren sits down with Tilly Dowler, know to many on social media as @The_Blind_Stylist.

• Podcast
• Audio

Gabriel Velichkova is in the second year of her Retina UK and Macular Society joint-funded PhD project at University College London (UCL) Institute of Ophthalmology.

• Case study - research
• Written

Ray Therapeutics, a clinical stage biopharmaceutical company, is currently investigating their lead optogenetic therapy candidate, RTx-015, in early stage clinical trials for those with RP and Choroideremia.

• News
• Choroideremia
• Retinitis pigmentosa

We are proud to work collaboratively with a number of corporate partners to enable our community to live fulfilled lives today as well as supporting the pharmaceutical industry in their mission to develop potential new treatments.

Biotechnology company Ocugen has announced the enrolment completion of their phase 3 clinical trial for OCU400.

• News
• Retinitis pigmentosa

Join us to find out how your donations make a direct different and fund research.

• Webinar
• Audio
• Video

Join us to find out how your donations make a direct different and fund research.

• Webinar

When Tilly Dowler talks about sight loss, she does so with honesty, humour and an infectious determination to make the most of every opportunity.

• Case study - community
• Written

Retina UK aims not only to progress research along established threads, but to stimulate new thinking, encourage innovative approaches and nurture original ideas.

Thank you to our fabulous 5K a Day in May supporters who raised more than £8,000 this year.

• Look Forward
• Audio
• Written